Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Artal International S.C.A. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
06/12/2023 SC 13G Artal International S.C.A. reports a 6.6% stake in Selecta Biosciences, Inc.
06/05/2023 4 Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Bought 27,775,050 shares @ $2.6, valued at $72.2M
05/12/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/11/2023 4 Westend S.A. (10% Owner) has filed a Form 4 on WW INTERNATIONAL, INC.
Txns: Sold 14,818,300 shares @ $7.15, valued at $106M
05/02/2023 4 Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp
Txns: Bought 31,557 shares @ $6.4279, valued at $202.8k
03/31/2023 SC 13G Artal International S.C.A. reports a 6.1% stake in Harpoon Therapeutics, Inc.
02/28/2023 4 Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Bought 100,000 shares @ $1.7, valued at $170k
02/23/2023 4 Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Bought 50,000 shares @ $1.85, valued at $92.5k
Bought 150,000 shares @ $1.7933, valued at $269k
Bought 200,000 shares @ $1.7538, valued at $350.8k
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/01/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/11/2023 4 Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp
Txns: Sold 1,094 shares @ $9.482, valued at $10.4k
01/09/2023 4 Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp
Txns: Bought 48,774 shares @ $9.3306, valued at $455.1k
11/14/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
10/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2022 4 Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp
Txns: Bought 33,971 shares @ $7.0292, valued at $238.8k
Bought 66,000 shares @ $7.8903, valued at $520.8k
08/23/2022 SC 13G Artal International S.C.A. reports a 6.4% stake in Vigil Neuroscience, Inc.
08/11/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/09/2022 4 Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Bought 2,426,070 shares @ $2.5, valued at $6.1M
08/05/2022 SC 13G Artal International S.C.A. reports a 6% stake in AlloVir, Inc.
08/01/2022 4 Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Bought 16,173,800 shares @ $2.5, valued at $40.4M
06/24/2022 SC 13G/A Artal International S.C.A. reports a 19.4% stake in Scholar Rock Holding Corporation
06/24/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
05/12/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/11/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/11/2022 SC 13G/A Artal International S.C.A. reports a 8.3% stake in SEER, INC.
02/11/2022 SC 13G/A Artal International S.C.A. reports a 8.2% stake in BELLUS Health Inc.
02/11/2022 SC 13G/A Artal International S.C.A. reports a 5.8% stake in IGM Biosciences, Inc.
02/11/2022 SC 13G/A Artal International S.C.A. reports a 6.4% stake in Cyclerion Therapeutics, Inc.
02/11/2022 SC 13G/A Artal International S.C.A. reports a 4.9% stake in Generation Bio Co.
02/11/2022 SC 13G/A Artal International S.C.A. reports a 7% stake in Scholar Rock Holding Corporation
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy